Severity of Scorpion Sting in Relation to Hematological Parameters
NCT04571411 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2020-10-14
Summary
The aim of this study is to investigate the relationship between severity of envenomation and hematological parameter by detectig initial mean platelet volume (MPV), neutrophil/lymphocyte ratio (NLR) and platelet/lymphocyte ratio (PLR) in pediatric patients presenting with a scorpion sting.
Conditions
- Scorpion Stings
Interventions
- OTHER
-
CBC
The aim of this study is to investigate the relationship between severity of envenomation and hematological parameter by detectig initial mean platelet volume (MPV), neutrophil/lymphocyte ratio (NLR) and platelet/lymphocyte ratio (PLR) in pediatric patients presenting with a scorpion sting.
Sponsors & Collaborators
-
Assiut University
lead OTHER
Principal Investigators
-
Yasser Gamal Abl Elrahman, lecture · Assiut University
Eligibility
- Min Age
- 0 Months
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-12-01
- Primary Completion
- 2023-03-01
- Completion
- 2023-09-01
More Related Trials
-
The Outcome of the Thrombopoietin Receptor Agonists in Pediatric Patient With Persistent or Chronic ITP Unresonsive to Steroids
NCT06568913 ·Status: RECRUITING ·Phase: NA
-
A Real-world Study of Herombopag in the Treatment of Thrombocytopenia Related Diseases in Henan Province
NCT05130424 ·Status: UNKNOWN
-
Thrombophilic Risk Factors in Pediatric Patients Diagnosed at the Ha'Emek Medical Center
NCT00736008 ·Status: COMPLETED
-
Safety of Oral Thrombopoietin Receptor Agonist in Pediatric Chronic ITP
NCT05846529 ·Status: UNKNOWN
-
Efficacy, Safety, Pharmacokinetics and Pharmacodynamics Study, Assessing Multiple LNP023 Doses in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria
NCT03896152 ·Status: COMPLETED ·Phase: PHASE2
-
Ultrasound to Detect Splenomegally in Patients With Isolated Thrombocytopenia
NCT07182760 ·Status: NOT_YET_RECRUITING
-
Study of CM313 (SC) Injection in Subjects With Primary Immune Thrombocytopenia (ITP)
NCT06594146 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Population Pharmacokinetic-pharmacodynamic Study of Rituximab in Children With Blood Diseases
NCT05324917 ·Status: UNKNOWN
-
Efficacy and Safety of Hetrombopag in Non-severe Aplastic Anemia
NCT05018936 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
A Study of Hetrombopag Olamine in Chronic Idiopathic Thrombocytopenic Purpura (ITP) Patients
NCT02403440 ·Status: UNKNOWN ·Phase: PHASE1
-
Platelet Glycoproteins in Inherited Thrombocytopathy: Association With Aggregation Studies and Bleeding Severity
NCT03648190 ·Status: UNKNOWN
-
Pediatric Disease Registry in Essential Thrombocythaemia (ET)
NCT01198717 ·Status: COMPLETED
-
Open Label Extension Study of AMG 531 in Japanese Subjects With ITP
NCT00440037 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Risk Factors and Predictors of Thrombosis in Myeloprolferative Neoplasms
NCT03599700 ·Status: UNKNOWN
-
High-dose Dexamethasone Plus Hetrombopag vs High-dose Dexamethasone Alone as Frontline Treatment for Newly Diagnosed Adult Primary Immune Thrombocytopenia: A Prospective, Multicenter, Randomized Trial
NCT05943691 ·Status: UNKNOWN ·Phase: PHASE2
-
NATURAL KILLER CELLS IN IMMUNOLOGIC THROMBOCYTOPENIC PURpura of Adults
NCT01172015 ·Status: COMPLETED ·Phase: NA
-
The Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HMPL-523 in Adult Subjects With Immune Thrombocytopenia (ITP)
NCT06291415 ·Status: WITHDRAWN ·Phase: PHASE1
-
The Association Between Platelet Reactivity and Bleeding Risk in Adult ITP
NCT03377439 ·Status: UNKNOWN
-
Childhood Reactive Thrombocytosis
NCT01230528 ·Status: COMPLETED
-
A Clinical Study of Herombopag in Tumors-associated Thrombocytopenia
NCT05350956 ·Status: UNKNOWN ·Phase: PHASE2
-
Immunological Markers in Adult Patients With Immune Thrombocytopenic Purpura
NCT04056507 ·Status: COMPLETED
-
A Clinical Study of Hetrombopag Olamine Tablets for Thrombocytopenia Induced by Anti-tumor Treatment in Advanced Breast Cancer
NCT05394285 ·Status: COMPLETED ·Phase: PHASE2
-
A Trial of Hetrombopag in Healthy Subjects
NCT05088174 ·Status: COMPLETED ·Phase: PHASE1
-
Extension Study of Herombopag for Pediatric Patients With Chronic Immune Thrombocytopenia
NCT05685420 ·Status: UNKNOWN ·Phase: PHASE3
-
Clinical Study on Efficacy and Safety of Hetrombopag in the Preoperative Patients of Thrombocytopenia
NCT06562738 ·Status: RECRUITING ·Phase: PHASE4